Insights: M&A

Mergers & Acquisitions

JNJ/Intra-Cellular

Executive Summary Since our initial update, we have gotten feedback from more physicians (who are users of most of the drugs in question and not involved in related clinical trials) suggesting that the proposed merger is unlikely to diminish competition to any substantial degree in the drug markets where the companies have overlapping indications....